[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Liebman", "title": "Associate Director of Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.0, "open": 1.07, "dayLow": 0.9628, "dayHigh": 1.07, "regularMarketPreviousClose": 1.0, "regularMarketOpen": 1.07, "regularMarketDayLow": 0.9628, "regularMarketDayHigh": 1.07, "payoutRatio": 0.0, "beta": 1.908, "forwardPE": -3.338621, "volume": 504638, "regularMarketVolume": 504638, "averageVolume": 175969, "averageVolume10days": 196820, "averageDailyVolume10Day": 196820, "bid": 0.9664, "ask": 1.23, "bidSize": 18, "askSize": 2, "marketCap": 86851600, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.59, "fiftyDayAverage": 0.81438, "twoHundredDayAverage": 0.84723, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3501872, "profitMargins": 0.0, "floatShares": 37696393, "sharesOutstanding": 89704194, "sharesShort": 521193, "sharesShortPriorMonth": 1207989, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0058, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.76785004, "shortRatio": 3.11, "shortPercentOfFloat": 0.0070999996, "impliedSharesOutstanding": 89704194, "bookValue": 0.92, "priceToBook": 1.0523913, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -34207572, "trailingEps": -0.43, "forwardEps": -0.29, "enterpriseToEbitda": -0.091, "52WeekChange": -0.5346154, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 0.9682, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.16667, "targetMedianPrice": 4.5, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 83517048, "totalCashPerShare": 0.931, "ebitda": -38285488, "totalDebt": 167319, "quickRatio": 18.333, "currentRatio": 19.087, "debtToEquity": 0.203, "returnOnAssets": -0.25215, "returnOnEquity": -0.37252998, "freeCashflow": -37020280, "operatingCashflow": -17703620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1758325596, "regularMarketTime": 1758312003, "shortName": "Context Therapeutics Inc.", "fiftyTwoWeekLowChangePercent": 0.9759184, "fiftyTwoWeekRange": "0.49 - 2.59", "fiftyTwoWeekHighChange": -1.6218, "fiftyTwoWeekHighChangePercent": -0.6261776, "fiftyTwoWeekChangePercent": -53.46154, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.43, "epsForward": -0.29, "epsCurrentYear": -0.31857, "priceEpsCurrentYear": -3.0392067, "fiftyDayAverageChange": 0.15382004, "fiftyDayAverageChangePercent": 0.18887994, "twoHundredDayAverageChange": 0.12097001, "twoHundredDayAverageChangePercent": 0.14278296, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -3.18, "regularMarketPrice": 0.9682, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "postMarketChangePercent": 0.258211, "postMarketPrice": 0.9707, "postMarketChange": 0.0025, "regularMarketChange": -0.0318, "regularMarketDayRange": "0.9628 - 1.07", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 175969, "fiftyTwoWeekLowChange": 0.47820002, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Context Therapeutics Inc.", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]